Cargando…
Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity
BACKGROUND: The collagen antibody-induced arthritis (CAIA) model, which employs a cocktail of monoclonal antibodies (mAbs) to type II collagen (CII), has been widely used for studying the pathogenesis of autoimmune arthritis. In this model, not all mAbs to CII are capable of inducing arthritis becau...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217917/ https://www.ncbi.nlm.nih.gov/pubmed/22054174 http://dx.doi.org/10.1186/1476-9255-8-31 |
_version_ | 1782216631521378304 |
---|---|
author | Koobkokkruad, Thongchai Kadotani, Tatsuya Hutamekalin, Pilaiwanwadee Mizutani, Nobuaki Yoshino, Shin |
author_facet | Koobkokkruad, Thongchai Kadotani, Tatsuya Hutamekalin, Pilaiwanwadee Mizutani, Nobuaki Yoshino, Shin |
author_sort | Koobkokkruad, Thongchai |
collection | PubMed |
description | BACKGROUND: The collagen antibody-induced arthritis (CAIA) model, which employs a cocktail of monoclonal antibodies (mAbs) to type II collagen (CII), has been widely used for studying the pathogenesis of autoimmune arthritis. In this model, not all mAbs to CII are capable of inducing arthritis because one of the initial events is the formation of collagen-antibody immune complexes on the cartilage surface or in the synovium, and subsequent activation of the complement by the complexes induces arthritis, suggesting that a combination of mAbs showing strong ability to bind mouse CII and activate the complement may effectively induce arthritis in mice. In the present study, we examined the relationship between the induction of arthritis by the combination of IgG2a (CII-6 and C2A-12), IgG2b (CII-3, C2B-14 and C2B-16) and IgM (CM-5) subclones of monoclonal antibodies (mAb) of anti-bovine or chicken CII and the ability of mAbs to activate complement and bind mouse CII. METHODS: DBA/1J mice were injected with several combinations of mAbs followed by lipopolysaccharide. Furthermore, the ability of mAbs to activate the complement and bind mouse CII was examined by ELISA. RESULTS: First, DBA/1J mice were injected with the combined 4 mAbs (CII-3, CII-6, C2B-14, and CM-5) followed by lipopolysaccharide, resulting in moderate arthritis. Excluding one of the mAbs, i.e., using only CII-3, CII-6, and C2B-14, induced greater inflammation of the joints. Next, adding C2A-12 but not C2B-16 to these 3 mAbs produced more severe arthritis. A combination of five clones, consisting of all 5 mAbs, was less effective. Histologically, mice given the newly developed 4-clone cocktail had marked proliferation of synovial tissues, massive infiltration by inflammatory cells, and severe destruction of cartilage and bone. Furthermore, 4 of the 6 clones (CII-3, CII-6, C2B-14, and C2A-12) showed not only a strong cross-reaction with mouse CII but also marked activation of the complement in vitro. CONCLUSION: The combination of 4 mAbs showing strong abilities to activate the complement and bind mouse CII effectively induced arthritis in DBA/1J mice. This in vitro system may be useful for the selection of mAbs associated with the development of arthritis. |
format | Online Article Text |
id | pubmed-3217917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32179172011-11-17 Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity Koobkokkruad, Thongchai Kadotani, Tatsuya Hutamekalin, Pilaiwanwadee Mizutani, Nobuaki Yoshino, Shin J Inflamm (Lond) Research BACKGROUND: The collagen antibody-induced arthritis (CAIA) model, which employs a cocktail of monoclonal antibodies (mAbs) to type II collagen (CII), has been widely used for studying the pathogenesis of autoimmune arthritis. In this model, not all mAbs to CII are capable of inducing arthritis because one of the initial events is the formation of collagen-antibody immune complexes on the cartilage surface or in the synovium, and subsequent activation of the complement by the complexes induces arthritis, suggesting that a combination of mAbs showing strong ability to bind mouse CII and activate the complement may effectively induce arthritis in mice. In the present study, we examined the relationship between the induction of arthritis by the combination of IgG2a (CII-6 and C2A-12), IgG2b (CII-3, C2B-14 and C2B-16) and IgM (CM-5) subclones of monoclonal antibodies (mAb) of anti-bovine or chicken CII and the ability of mAbs to activate complement and bind mouse CII. METHODS: DBA/1J mice were injected with several combinations of mAbs followed by lipopolysaccharide. Furthermore, the ability of mAbs to activate the complement and bind mouse CII was examined by ELISA. RESULTS: First, DBA/1J mice were injected with the combined 4 mAbs (CII-3, CII-6, C2B-14, and CM-5) followed by lipopolysaccharide, resulting in moderate arthritis. Excluding one of the mAbs, i.e., using only CII-3, CII-6, and C2B-14, induced greater inflammation of the joints. Next, adding C2A-12 but not C2B-16 to these 3 mAbs produced more severe arthritis. A combination of five clones, consisting of all 5 mAbs, was less effective. Histologically, mice given the newly developed 4-clone cocktail had marked proliferation of synovial tissues, massive infiltration by inflammatory cells, and severe destruction of cartilage and bone. Furthermore, 4 of the 6 clones (CII-3, CII-6, C2B-14, and C2A-12) showed not only a strong cross-reaction with mouse CII but also marked activation of the complement in vitro. CONCLUSION: The combination of 4 mAbs showing strong abilities to activate the complement and bind mouse CII effectively induced arthritis in DBA/1J mice. This in vitro system may be useful for the selection of mAbs associated with the development of arthritis. BioMed Central 2011-11-04 /pmc/articles/PMC3217917/ /pubmed/22054174 http://dx.doi.org/10.1186/1476-9255-8-31 Text en Copyright ©2011 Koobkokkruad et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Koobkokkruad, Thongchai Kadotani, Tatsuya Hutamekalin, Pilaiwanwadee Mizutani, Nobuaki Yoshino, Shin Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity |
title | Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity |
title_full | Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity |
title_fullStr | Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity |
title_full_unstemmed | Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity |
title_short | Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity |
title_sort | arthrogenicity of type ii collagen monoclonal antibodies associated with complement activation and antigen affinity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217917/ https://www.ncbi.nlm.nih.gov/pubmed/22054174 http://dx.doi.org/10.1186/1476-9255-8-31 |
work_keys_str_mv | AT koobkokkruadthongchai arthrogenicityoftypeiicollagenmonoclonalantibodiesassociatedwithcomplementactivationandantigenaffinity AT kadotanitatsuya arthrogenicityoftypeiicollagenmonoclonalantibodiesassociatedwithcomplementactivationandantigenaffinity AT hutamekalinpilaiwanwadee arthrogenicityoftypeiicollagenmonoclonalantibodiesassociatedwithcomplementactivationandantigenaffinity AT mizutaninobuaki arthrogenicityoftypeiicollagenmonoclonalantibodiesassociatedwithcomplementactivationandantigenaffinity AT yoshinoshin arthrogenicityoftypeiicollagenmonoclonalantibodiesassociatedwithcomplementactivationandantigenaffinity |